SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-081211
Filing Date
2022-07-20
Accepted
2022-07-20 17:10:46
Documents
13
Period of Report
2022-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221453d1_8k.htm   iXBRL 8-K 29484
2 EXHIBIT 10.1 tm2221453d1_ex10-1.htm EX-10.1 288647
  Complete submission text file 0001104659-22-081211.txt   551800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20220719.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20220719_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20220719_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2221453d1_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 221094868
SIC: 2834 Pharmaceutical Preparations